Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: data from the prospective Second Manifestations of ARTerial disease (SMART) cohort study.

[1]  Deepak L. Bhatt,et al.  Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. , 2009, Atherosclerosis.

[2]  J. Manson,et al.  Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. , 2008, JAMA.

[3]  J. Regensteiner,et al.  Risk assessment in the patient with established peripheral arterial disease , 2007, Vascular medicine.

[4]  M. Pfeffer,et al.  Prognostic Significance of the Centers for Disease Control/American Heart Association High-Sensitivity C-Reactive Protein Cut Points for Cardiovascular and Other Outcomes in Patients With Stable Coronary Artery Disease , 2007, Circulation.

[5]  Deepak L. Bhatt,et al.  One-year cardiovascular event rates in outpatients with atherothrombosis. , 2007, JAMA.

[6]  Juan Lu,et al.  Statistical approaches to the univariate prognostic analysis of the IMPACT database on traumatic brain injury. , 2007, Journal of neurotrauma.

[7]  E. Minar,et al.  No effect of homocysteine‐lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease , 2006, European journal of clinical investigation.

[8]  Deepak L. Bhatt,et al.  International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. , 2006, JAMA.

[9]  G. Hankey.  Vascular disease of the heart, brain and limbs: new insights into a looming epidemic , 2005, The Lancet.

[10]  P. Ridker,et al.  Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). , 2005, The American journal of cardiology.

[11]  J. Burgerhof,et al.  The association between atherosclerotic risk factors and renal function in the general population. , 2005, Kidney international.

[12]  R. Gans,et al.  C-reactive protein is associated with renal function abnormalities in a non-diabetic population. , 2003, Kidney international.

[13]  M. Criqui,et al.  Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care , 2001 .

[14]  D. Hunninghake,et al.  The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care , 2001 .

[15]  S. D. Jong.  Hyperhomocysteinaemia in Patients with Peripheral Arterial Occlusive Disease , 2001 .

[16]  A. Algra,et al.  Second Manifestations of ARTerial disease (SMART) study: Rationale and design , 1999, European Journal of Epidemiology.

[17]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[18]  S Greenland,et al.  A critical look at methods for handling missing covariates in epidemiologic regression analyses. , 1995, American journal of epidemiology.

[19]  H. Akaike.  A new look at the statistical model identification , 1974 .

[20]  John V. White,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.